Merck is setting up a new bio-production centre dedicated to the development and manufacture of biotechnological drugs.
The facility consists of a building with a total of 15,700 m2 of development space available to a multidisciplinary team of some 250 employees, including two platforms organised in an innovative flexlab, a pilot plant and clean rooms for production.
The teams develop life science solutions for clinical manufacturing and pilot plant operations.
It brings together a unique combination of research and production dedicated to clinical trials that will ensure that the next generation of biotech therapies, especially against cancer, will be available for clinical trials in the time, quality and quantity needed.
The centre is equipped with the most advanced digital and technological solutions, especially for continuous manufacturing (upstream and downstream processes) and laboratory automation (robotisation).
It offers a flexible infrastructure to easily adapt to emerging needs and technological changes, as well as open workspaces for collaboration, creativity and innovation.
Everything is designed to meet the highest international standards of quality, environment, health and safety.
- WFI water production by membrane process (world first).
- NWoW Collaborative workspaces.
- L2 Labs.
- Salles blanches grade C et D.
- Gestion intelligente par écrans tactiles.
- Photovoltaic production plant.
- LED glazing for solar control (innovation).
Patriarche (Architecture, Interior Design, EQB, BIM)
Patriarche Ingénierie (TCE, economy)
Patriarche DB (project management)
Patriarche Creative (design, communication)
BG ingénieurs conseils
Amstein + Walthert